U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07242469) titled 'A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)' on Nov. 17.
Brief Summary: The purpose of this study is to learn about the safety and if people tolerate a study medicine called MK-1403. The study will also measure what happens to MK-1403 in the body of a person with type 2 diabetes (T2D) over time (pharmacokinetic or PK study), and how it affects the amount of high-sensitivity C-reactive protein (hsCRP) in a person's blood.
Study Start Date: Dec. 18
Study Type: INTERVENTIONAL
Condition:
Diabetes Mellitus, Type 2
Intervention:
DRUG: MK-1403 + additive coformulation
MK-1403 + additive co...